BlackRock, Inc. 13D and 13G filings for Revolution Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | Revolution Medicines, Inc. RVMD | BlackRock Inc. BLK | 8,399,214 4.500% | -4,555,100 (-35.16%) | Filing |
| 2024-01-26 11:49 am Purchase | 2023-12-31 | 13G | Revolution Medicines, Inc. RVMD | BlackRock Inc. BLK | 12,954,314 7.900% | 6,378,368 (+97.00%) | Filing |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | Revolution Medicines, Inc. RVMD | BlackRock Inc. BLK | 6,575,946 7.400% | 1,100,727 (+20.10%) | Filing |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | Revolution Medicines, Inc. RVMD | BlackRock Inc. BLK | 5,475,219 7.400% | 1,963,132 (+55.90%) | Filing |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Revolution Medicines, Inc. RVMD | BlackRock Inc. BLK | 3,512,087 5.300% | 3,512,087 (New Position) | Filing |